This is a StreetInsider.com Premium Only Page

VIVUS (VVUS) – Major News

Nov 7, 2017 04:13 PM VIVUS (VVUS) Tops Q2 EPS by 7c

May 3, 2017 04:26 PM VIVUS (VVUS) Tops Q1 EPS by 13c

Mar 8, 2017 04:12 PM VIVUS (VVUS) Tops Q4 EPS by 31c

Nov 9, 2016 04:15 PM VIVUS (VVUS) Tops Q3 EPS by 28c; Board Approves NOL Rights Plan

Aug 4, 2016 05:08 PM VIVUS (VVUS) Tops Q2 EPS by 20c

May 3, 2016 04:08 PM VIVUS (VVUS) Tops Q1 EPS by 9c

Mar 9, 2016 04:16 PM VIVUS (VVUS) Reports In-Line Q4 Loss of 12c/Share

Nov 4, 2015 04:20 PM VIVUS (VVUS) Tops Q3 EPS by 2c, Revenue Beats

Jul 30, 2015 04:01 PM VIVUS (VVUS) Tops Q2 EPS by 5c

May 5, 2015 04:03 PM VIVUS (VVUS) Tops Q1 EPS by 7c

Feb 24, 2015 04:01 PM VIVUS (VVUS) Reports In-Line Q4 EPS

Nov 5, 2014 04:01 PM VIVUS (VVUS) Posts Q3 Loss of 3c/Share

Aug 7, 2014 04:10 PM VIVUS, Inc. (VVUS) Posts Q2 Loss of 25c/Share

May 28, 2014 09:56 AM Aspen Investment Plans to Hold Talks with VIVUS, Inc. (VVUS) Management; Considers $640M Bid

May 5, 2014 04:02 PM VIVUS, Inc. (VVUS) Posts Q1 Loss of 15c/Share

Feb 24, 2014 04:01 PM VIVUS, Inc. (VVUS) Posts Q4 Loss of 17c/Share

Nov 5, 2013 04:01 PM VIVUS, Inc. (VVUS) Posts Q3 Loss of 48c/Share

Sep 3, 2013 07:01 AM VIVUS (VVUS) CEO Zook Resigns; Seth H. Z. Fischer to Assume Role

Aug 6, 2013 04:07 PM VIVUS, Inc. (VVUS) Posts Q2 Loss of 55c/Share; Updates on Qsymia TRx

Jul 23, 2013 06:24 AM VIVUS, Inc. (VVUS) Names Anthony Zook as CEO, Michael Astrue as Chair

Jul 19, 2013 07:00 AM VIVUS (VVUS), First Manhattan, Sarissa Enter Proxy Settlement

Jul 5, 2013 06:44 AM ISS, Egan Jones Support First Manhattan in VIVUS (VVUS) Board Battle

May 8, 2013 07:31 AM VIVUS, Inc. (VVUS) Posts Q1 Loss of 53c/Share

Feb 25, 2013 04:48 PM UPDATE: VIVUS, Inc. (VVUS) Posts Q4 Loss of 56c/Share

Feb 21, 2013 05:01 PM EMA CHMP Declines VIVUS (VVUS) MAA for Qsiva

Nov 6, 2012 08:56 AM VIVUS (VVUS) Ticks Lower; Wider Q3 Loss Attributed to Qsymia Launch, Expansion (ARNA) (OREX)

Nov 6, 2012 08:16 AM VIVUS, Inc. (VVUS) Posts Wider than Expected Q3 Loss of 40c/Share

Oct 18, 2012 05:31 PM VIVUS (VVUS) Formally Denied MAA for Qsiva by CHMP; Cites Concern Over Cadio, Nervous System Effects

Sep 17, 2012 06:34 AM VIVUS (VVUS) Announces U.S. Market Availability of Qsymia

Jul 18, 2012 09:08 AM VIVUS' (VVUS) Qsymia Approved and has Advantages Over Belviq

Jul 17, 2012 07:20 PM FDA Approves VIVUS (VVUS) Weight-Management Drug Qsymia

May 7, 2012 04:01 PM Vivus, Inc. (VVUS) Misses Q1 EPS by 7c

Apr 9, 2012 04:46 PM FDA Extends PDUFA Date for VIVUS's (VVUS) Qnexa NDA to July 17th

Feb 28, 2012 05:16 PM Vivus, Inc. (VVUS) Reports Wider than Expected Operating Loss of 14c/Share

Feb 22, 2012 05:43 PM VIVUS (VVUS) Confirms FDA Panel Recommends Approval of Qnexa for Obesity

Nov 7, 2011 04:01 PM Vivus, Inc. (VVUS) Posts Q3 Loss of 10c/Share

Aug 1, 2011 04:28 PM Vivus, Inc. (VVUS) Posts Q2 EPS Loss of $0.20

May 2, 2011 04:15 PM VIVUS Inc. (VVUS) Reports Q1 Loss of $0.12/Share

Feb 28, 2011 04:05 PM VIVUS Inc. (VVUS) Misses Q4 EPS by 1c

Nov 8, 2010 04:01 PM Vivus (VVUS) Posts Q3 Loss of $0.22, Narrower than Views

Oct 29, 2010 07:04 AM VIVUS (VVUS) Receives CRL From FDA on QNEXA, Expects Response in 6 Weeks

Aug 2, 2010 04:12 PM Vivus (VVUS) Posts Q2 Loss of $0.28, Misses Views

Jul 15, 2010 05:44 PM VIVUS (VVUS) Comments of U.S. FDA Committee Decision Regarding Qnexa

May 3, 2010 04:12 PM Vivus (VVUS) Q1 Loss Smaller by 3c

Mar 8, 2010 04:02 PM Vivus (VVUS) Posts Narrower than Expected Q4 Loss of $0.16

Mar 1, 2010 07:10 AM FDA Accepts VIVUS (VVUS) NDA for Qnexa for Obesity

Nov 3, 2009 04:29 PM Vivus (VVUS) Posts Q3 Loss of $0.30, Tops by 1c

Sep 9, 2009 07:02 AM VIVUS (VVUS) Said EQUIP and CONQUER Studies Met All Primary Endpoints

Aug 11, 2009 04:04 PM VIVUS (VVUS) Reports Better-Than-Expected Q2 Loss of $0.19

May 11, 2009 04:06 PM Vivus (VVUS) Reports Q1 Loss of $0.10, Misses by 3c